NORDSON CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NORDSON CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Oct 31, 2018 | $569.30M | Dec 14, 2018 |
| FY2018 | Jul 31, 2018 | $581.24M | Dec 14, 2018 |
| FY2018 | Apr 30, 2018 | $553.71M | Dec 14, 2018 |
| FY2018 | Jan 31, 2018 | $550.42M | Dec 14, 2018 |
| FY2018 | Oct 31, 2017 | $573.94M | Dec 14, 2018 |
| FY2018 | Jul 31, 2017 | $589.44M | Dec 14, 2018 |
| FY2018 | Apr 30, 2017 | $496.14M | Dec 14, 2018 |
| FY2018 | Jan 31, 2017 | $407.47M | Dec 14, 2018 |
| FY2018 | Oct 31, 2016 | $1.81B | Dec 14, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $2.79B | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $2.69B | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $2.63B | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $2.59B | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $2.36B | Dec 20, 2023 |
| FY2020 | Oct 31, 2020 | $558.53M | Dec 18, 2020 |
| FY2020 | Jul 31, 2020 | $538.18M | Dec 18, 2020 |
| FY2020 | Apr 30, 2020 | $529.48M | Dec 18, 2020 |
| FY2020 | Jan 31, 2020 | $494.92M | Dec 18, 2020 |
| FY2020 | Oct 31, 2019 | $585.45M | Dec 18, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Oct 31, 2017 | $573.94M | Dec 15, 2017 |
| FY2017 | Jul 31, 2017 | $589.44M | Dec 15, 2017 |
| FY2017 | Apr 30, 2017 | $496.14M | Dec 15, 2017 |
| FY2017 | Jan 31, 2017 | $407.47M | Dec 15, 2017 |
| FY2016 | Oct 31, 2016 | $509.28M | Dec 15, 2016 |
| FY2016 | Jul 31, 2016 | $489.90M | Dec 15, 2016 |
| FY2016 | Apr 30, 2016 | $437.59M | Dec 15, 2016 |
| FY2016 | Jan 31, 2016 | $372.22M | Dec 15, 2016 |
| FY2015 | Oct 31, 2015 | $446.20M | Dec 15, 2015 |
| FY2015 | Jul 31, 2015 | $462.73M | Dec 15, 2015 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Oct 31, 2020 | $296.87M | Dec 18, 2020 |
| FY2020 | Jul 31, 2020 | $280.81M | Dec 18, 2020 |
| FY2020 | Apr 30, 2020 | $289.60M | Dec 18, 2020 |
| FY2020 | Jan 31, 2020 | $263.19M | Dec 18, 2020 |
| FY2020 | Oct 31, 2019 | $318.98M | Dec 18, 2020 |
| FY2020 | Jul 31, 2019 | $302.62M | Dec 18, 2020 |
| FY2020 | Apr 30, 2019 | $301.53M | Dec 18, 2020 |
| FY2020 | Jan 31, 2019 | $268.98M | Dec 18, 2020 |
| FY2018 | Oct 31, 2018 | $307.74M | Dec 14, 2018 |
| FY2018 | Jul 31, 2018 | $320.40M | Dec 14, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $484.47M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $467.28M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $487.49M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $513.10M | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $454.37M | Dec 20, 2023 |
| FY2020 | Oct 31, 2020 | $18.48M | Dec 18, 2020 |
| FY2020 | Jul 31, 2020 | $86.98M | Dec 18, 2020 |
| FY2020 | Apr 30, 2020 | $92.08M | Dec 18, 2020 |
| FY2020 | Jan 31, 2020 | $52.00M | Dec 18, 2020 |
| FY2020 | Oct 31, 2019 | $102.67M | Dec 18, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $711.73M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $674.00M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $672.76M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $702.36M | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $615.13M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $349.55M | Dec 19, 2022 |
| FY2021 | Oct 31, 2019 | $483.11M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $502.58M | Dec 18, 2020 |
| FY2019 | Oct 31, 2017 | $466.40M | Dec 13, 2019 |
| FY2018 | Oct 31, 2016 | $388.43M | Dec 14, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $68.24M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $64.99M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $71.40M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $52.53M | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $59.42M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $63.59M | Dec 19, 2022 |
| FY2021 | Oct 31, 2019 | $60.02M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $58.81M | Dec 18, 2020 |
| FY2019 | Oct 31, 2017 | $52.46M | Dec 13, 2019 |
| FY2018 | Oct 31, 2016 | $46.25M | Dec 14, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $815.51M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $812.13M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $752.64M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $724.18M | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $708.95M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $693.55M | Dec 19, 2022 |
| FY2021 | Oct 31, 2019 | $708.99M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $733.75M | Dec 18, 2020 |
| FY2019 | Oct 31, 2017 | $672.89M | Dec 13, 2019 |
| FY2018 | Oct 31, 2016 | $605.07M | Dec 14, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $719.18M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $556.19M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $641.28M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $513.13M | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $545.93M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $502.42M | Dec 19, 2022 |
| FY2021 | Oct 31, 2019 | $382.89M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $504.64M | Dec 18, 2020 |
| FY2019 | Oct 31, 2017 | $356.75M | Dec 13, 2019 |
| FY2018 | Oct 31, 2016 | $334.63M | Dec 14, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $58.06M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $64.41M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $34.58M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $51.43M | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $38.30M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $50.54M | Dec 19, 2022 |
| FY2021 | Oct 31, 2019 | $64.24M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $89.79M | Dec 18, 2020 |
| FY2019 | Oct 31, 2017 | $71.56M | Dec 13, 2019 |
| FY2018 | Oct 31, 2016 | $60.85M | Dec 14, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $5.92B | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $6.00B | Dec 17, 2025 |
| FY2024 | Oct 31, 2023 | $5.25B | Dec 18, 2024 |
| FY2024 | Oct 31, 2022 | $3.82B | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $3.79B | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $3.67B | Dec 19, 2022 |
| FY2021 | Oct 31, 2019 | $3.52B | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $3.42B | Dec 18, 2020 |
| FY2019 | Oct 31, 2017 | $3.41B | Dec 13, 2019 |
| FY2018 | Oct 31, 2016 | $2.42B | Dec 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $3.04B | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $2.93B | Dec 17, 2025 |
| FY2024 | Oct 31, 2023 | $2.60B | Dec 18, 2024 |
| FY2023 | Oct 31, 2022 | $2.29B | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | $2.16B | Dec 19, 2022 |
| FY2021 | Oct 31, 2020 | $1.76B | Dec 17, 2021 |
| FY2020 | Oct 31, 2019 | $1.58B | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | $1.45B | Dec 13, 2019 |
| FY2018 | Oct 31, 2017 | $1.16B | Dec 14, 2018 |
| FY2017 | Oct 31, 2016 | $851.60M | Dec 15, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $3.30B | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $3.28B | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $2.78B | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $1.80B | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $1.71B | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $1.71B | Dec 19, 2022 |
| FY2021 | Oct 31, 2019 | $1.61B | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $1.61B | Dec 18, 2020 |
| FY2019 | Oct 31, 2017 | $1.59B | Dec 13, 2019 |
| FY2018 | Oct 31, 2016 | $1.11B | Dec 14, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $4.60B | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $4.30B | Dec 17, 2025 |
| FY2024 | Oct 31, 2023 | $3.99B | Dec 18, 2024 |
| FY2023 | Oct 31, 2022 | $3.65B | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | $3.27B | Dec 19, 2022 |
| FY2021 | Oct 31, 2020 | $2.91B | Dec 17, 2021 |
| FY2020 | Oct 31, 2019 | $2.75B | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | $2.49B | Dec 13, 2019 |
| FY2018 | Oct 31, 2017 | $2.16B | Dec 14, 2018 |
| FY2017 | Oct 31, 2016 | $1.93B | Dec 15, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $108.44M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $115.95M | Dec 17, 2025 |
| FY2024 | Oct 31, 2023 | $115.68M | Dec 18, 2024 |
| FY2023 | Oct 31, 2022 | $163.46M | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | $299.97M | Dec 19, 2022 |
| FY2021 | Oct 31, 2020 | $208.29M | Dec 17, 2021 |
| FY2020 | Oct 31, 2019 | $151.16M | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | $95.68M | Dec 13, 2019 |
| FY2018 | Oct 31, 2017 | $90.38M | Dec 14, 2018 |
| FY2017 | Oct 31, 2016 | $67.24M | Dec 15, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $2.00B | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $2.19B | Dec 17, 2025 |
| FY2024 | Oct 31, 2023 | $1.73B | Dec 18, 2024 |
| FY2023 | Oct 31, 2022 | $737.86M | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | $812.35M | Dec 19, 2022 |
| FY2021 | Oct 31, 2020 | $1.11B | Dec 17, 2021 |
| FY2020 | Oct 31, 2019 | $1.24B | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | $1.31B | Dec 13, 2019 |
| FY2018 | Oct 31, 2017 | $1.58B | Dec 14, 2018 |
| FY2017 | Oct 31, 2016 | $980.86M | Dec 15, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 8 | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | 8 | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | 8 | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | 8 | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | 7 | Dec 20, 2023 |
| FY2020 | Oct 31, 2020 | 0 | Dec 18, 2020 |
| FY2020 | Jul 31, 2020 | 1 | Dec 18, 2020 |
| FY2020 | Apr 30, 2020 | 1 | Dec 18, 2020 |
| FY2020 | Jan 31, 2020 | 0 | Dec 18, 2020 |
| FY2020 | Oct 31, 2019 | 1 | Dec 18, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 8 | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | 8 | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | 8 | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | 8 | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | 7 | Dec 20, 2023 |
| FY2020 | Oct 31, 2020 | 0 | Dec 18, 2020 |
| FY2020 | Jul 31, 2020 | 1 | Dec 18, 2020 |
| FY2020 | Apr 30, 2020 | 1 | Dec 18, 2020 |
| FY2020 | Jan 31, 2020 | 0 | Dec 18, 2020 |
| FY2020 | Oct 31, 2019 | 1 | Dec 18, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 55.92M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | 57.20M | Dec 17, 2025 |
| FY2024 | Oct 31, 2023 | 57.01M | Dec 18, 2024 |
| FY2023 | Oct 31, 2022 | 57.11M | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | 58.15M | Dec 19, 2022 |
| FY2021 | Oct 31, 2020 | 58.08M | Dec 17, 2021 |
| FY2020 | Oct 31, 2019 | 57.60M | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | 58.04M | Dec 13, 2019 |
| FY2018 | Oct 31, 2017 | 57.72M | Dec 14, 2018 |
| FY2017 | Oct 31, 2016 | 57.31M | Dec 15, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $179.07M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $161.44M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $150.36M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $125.91M | Dec 18, 2024 |
| FY2023 | Oct 31, 2021 | $97.68M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $88.35M | Dec 19, 2022 |
| FY2021 | Oct 31, 2019 | $82.15M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $72.44M | Dec 18, 2020 |
| FY2019 | Oct 31, 2017 | $63.84M | Dec 13, 2019 |
| FY2018 | Oct 31, 2016 | $56.44M | Dec 14, 2018 |